Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02580448
Title A Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of VT-464 in Patients With Advanced Breast Cancer
Acronym CLARITY-01
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Innocrin Pharmaceutical
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.